Skip to main content

Advertisement

SpringerLink
Log in

Prospective study of low-dose cyclosporine A in patients with refractory lupus nephritis

  • ORIGINAL ARTICLE
  • Published:
Modern Rheumatology

Abstract

We evaluated the efficacy and safety of low-dose cyclosporine A (CsA) in patients with refractory lupus nephritis. Nine patients with systemic lupus erythematosus who had lupus nephritis resistant to previous treatment with glucocorticoids and immunosuppressants other than CsA were enrolled in a prospective, open-label study. All patients initially received 2.5 mg/kg per day of CsA; the dosage was adjusted to reach a blood trough level of 80–150 ng/ml. The urinary protein concentration decreased significantly 2 weeks after the initiation of treatment. After 30 weeks of CsA treatment, the mean urinary protein concentration was more than 50% lower than the baseline value, and urinary casts had decreased significantly. There were no significant changes in the levels of serum creatinine, serum anti-double-stranded DNA antibodies, or CH50 during any part of the study. The dose of glucocorticoids was significantly tapered by approximately 50%, without any disease flare. Hypertension developed in one patient, but was controlled with antihypertensive agents. Our results suggest that low-dose CsA therapy is an effective and less toxic alternative to conventional cyclophosphamide therapy for the management of refractory lupus nephritis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. EM Tan (1982) ArticleTitleSpecial antibodies for the study of systemic lupus erythematosus and analysis Arthritis Rheum 25 753–6 Occurrence Handle6980650 Occurrence Handle10.1002/art.1780250707 Occurrence Handle1:STN:280:DyaL383ls1Ohsg%3D%3D

    Article  PubMed  CAS  Google Scholar 

  2. C Harmon (1985) ArticleTitleAntinuclear antibodies in autoimmune disease: significance and pathogenicity Med Clin North Am 69 547–63 Occurrence Handle3892191 Occurrence Handle1:STN:280:DyaL2M3jvFagtg%3D%3D

    PubMed  CAS  Google Scholar 

  3. D Koffler TE Miller I Fairferman (1983) ArticleTitleAntipoly-nucleotide antibodies: the rheumatic connection Hum Pathol 14 406–18 Occurrence Handle6188676 Occurrence Handle1:CAS:528:DyaL3sXkt1Slurc%3D

    PubMed  CAS  Google Scholar 

  4. EM Tan (1983) ArticleTitleAntinuclear antibodies in diagnosis and management Hosp Pract 18 78–84

    Google Scholar 

  5. EM Tan JP Portonova (1981) ArticleTitleThe role of histones as nuclear autoantigens in drug-related lupus erythematosus Arthritis Rheum 24 1064–9 Occurrence Handle7025842 Occurrence Handle10.1002/art.1780240813 Occurrence Handle1:CAS:528:DyaL3MXlvVGntr0%3D

    Article  PubMed  CAS  Google Scholar 

  6. Kotzin B.L. Systemic lupus erythematosus. Cell 85:303

  7. DD Gladman MB Urowitz (2002) Prognosis, mortality, and morbidity in systemic lupus erythematosus DJ Wallace BH Hahn (Eds) Dubois' lupus erythematosus EditionNumber6th ed Lippincott Williams & Wilkins Philadelphia 1255–73

    Google Scholar 

  8. S Takei N Maeno M Shigemori H Imanaka H Mori Y Nerome et al. (1997) ArticleTitleClinical features of Japanese children and adolescents with systemic lupus erythematosus: results of 1980–1994 survey Acta Pediatr Jpn 39 250–6 Occurrence Handle1:STN:280:DyaK2s3os1Srsw%3D%3D

    CAS  Google Scholar 

  9. RB Gibbons E Westerman (1988) ArticleTitleAcute nonlymphocytic leukemia following short-term, intermittent, intravenous cyclophosphamide treatment of lupus nephritis Arthritis Rheum 31 1552–4 Occurrence Handle3196367 Occurrence Handle10.1002/art.1780311212 Occurrence Handle1:STN:280:DyaL1M%2FmtFOqsA%3D%3D

    Article  PubMed  CAS  Google Scholar 

  10. S Vasquez AF Kavanaugh NR Schneider MC Wacholtz PE Lipsky (1992) ArticleTitleAcute nonlymphocytic leukemia after treatment of systemic lupus erythematosus with immunosuppressive agents J Rheumatol 19 1625–7 Occurrence Handle1464880 Occurrence Handle1:STN:280:DyaK3s7gtVOjuw%3D%3D

    PubMed  CAS  Google Scholar 

  11. DT Boumpas HA Austin EM Vaughan JH Klippel AD Steinberg CH Yarboro et al. (1992) ArticleTitleControlled trial of pulse methylprednisone versus two regimens of pulse cyclophosphamide in severe lupus nephritis Lancet 340 741–5 Occurrence Handle1356175 Occurrence Handle10.1016/0140-6736(92)92292-N Occurrence Handle1:STN:280:DyaK38vgvVentQ%3D%3D

    Article  PubMed  CAS  Google Scholar 

  12. DT Boumpas HA Austin EM Vaughan CH Yarboro JH Klippel JE Balow (1993) ArticleTitleRisk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy Ann Intern Med 119 366–9 Occurrence Handle8338289 Occurrence Handle1:STN:280:DyaK3szjt1eitg%3D%3D

    PubMed  CAS  Google Scholar 

  13. EM McDermott RJ Powell (1996) ArticleTitleIncidence of ovarian failure in systemic lupus erythematosus after treatment with pulse cyclophosphamide Ann Rheum Dis 55 224–9 Occurrence Handle8733438 Occurrence Handle1:CAS:528:DyaK28XislGqsL0%3D Occurrence Handle10.1136/ard.55.4.224

    Article  PubMed  CAS  Google Scholar 

  14. CC Mok CS Lau RW Wong (1998) ArticleTitleRisk factors for ovarian failure in patients with systemic lupus erythematosus receiving cyclophosphamide therapy Arthritis Rheum 41 831–7 Occurrence Handle9588734 Occurrence Handle10.1002/1529-0131(199806)41:6<1090::AID-ART16>3.0.CO;2-6 Occurrence Handle1:CAS:528:DyaK1cXjtlSjurs%3D

    Article  PubMed  CAS  Google Scholar 

  15. BD Kahan (1989) ArticleTitleCyclosporine N Engl J Med 321 1725–34 Occurrence Handle2687689 Occurrence Handle1:CAS:528:DyaK3cXkvVWnsQ%3D%3D Occurrence Handle10.1056/NEJM198912213212507

    Article  PubMed  CAS  Google Scholar 

  16. G Feutren (1989) ArticleTitleCyclosporine A: recent development in the mechanisms of action and clinical application Curr Opin Immunol 2 239–45 Occurrence Handle2696486 Occurrence Handle10.1016/0952-7915(89)90194-5 Occurrence Handle1:CAS:528:DyaK3MXlvFOmt7g%3D

    Article  PubMed  CAS  Google Scholar 

  17. E Bloemena MH van Oers S Weinreich SL Yong PT Schellekens (1988) ArticleTitlePrednisolone and cyclosporin A exert differential inhibitory effects on T-cell proliferation in vitro Clin Immunol Immunopathol 48 380–91 Occurrence Handle3261215 Occurrence Handle10.1016/0090-1229(88)90032-3 Occurrence Handle1:CAS:528:DyaL1cXlvVeiurk%3D

    Article  PubMed  CAS  Google Scholar 

  18. RY Calne DJ White S Thiru DB Evans P McMaster DC Dunn et al. (1978) ArticleTitleCyclosporin A in patients receiving renal allografts from cadaver donors Lancet 2 1323–7 Occurrence Handle82836 Occurrence Handle10.1016/S0140-6736(78)91970-0 Occurrence Handle1:STN:280:DyaE1M%2FntFyktA%3D%3D

    Article  PubMed  CAS  Google Scholar 

  19. JD Mountz HR Smith RL Wilder JP Reeves AD Steinberg (1987) ArticleTitleCS-A therapy in MRL-lpr/lpr mice: amelioration of immunopathology despite autoantibody production J Immunol 138 157–63 Occurrence Handle3537128 Occurrence Handle1:CAS:528:DyaL2sXnvVCnsw%3D%3D

    PubMed  CAS  Google Scholar 

  20. MC Hochberg (1997) ArticleTitleUpdating American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus Arthritis Rheum 40 1725 Occurrence Handle9324032 Occurrence Handle10.1002/art.1780400928 Occurrence Handle1:STN:280:DyaK2svmsVaisw%3D%3D

    Article  PubMed  CAS  Google Scholar 

  21. MF Gourley HA Austin Suffix3rd D Scott CH Yarboro EM Vaughan J Muir et al. (1996) ArticleTitleMethylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial Ann Intern Med 125 549–57 Occurrence Handle8815753 Occurrence Handle1:CAS:528:DyaK28XmsFClsLs%3D

    PubMed  CAS  Google Scholar 

  22. A Valeri J Radhakrishnan D Estes V D'Agati R Kopelman A Pernis et al. (1994) ArticleTitleIntravenous pulse cyclophosphamide treatment of severe lupus nephritis: a prospective five-year study Clin Nephrol 42 71–8 Occurrence Handle7955581 Occurrence Handle1:STN:280:DyaK2M%2FktlKjtw%3D%3D

    PubMed  CAS  Google Scholar 

  23. DA Isenberg ML Snaith WJ Morrow AA Al-Khader SL Cohen C Fisher et al. (1981) ArticleTitleCyclosporin A for the treatment of systemic lupus erythematosus Int J Immunopharmacol 3 163–9 Occurrence Handle7021435 Occurrence Handle10.1016/0192-0561(81)90007-2 Occurrence Handle1:STN:280:DyaL3M3mtlWnsQ%3D%3D

    Article  PubMed  CAS  Google Scholar 

  24. P Deteix N Lefrancois M Laville S Colon P Zech J Traeger (1985) Open therapeutic trial of cyclosporin in systemic lupus erythematosus. Preliminary results in 4 patients Schindler R (Eds) Cyclosporin in autoimmune diseases Springer Berlin 361–5

    Google Scholar 

  25. WM Awni (1992) ArticleTitlePharmacodynamic monitoring of cyclosporin Clin Pharmacokinet 23 428–48 Occurrence Handle1458762 Occurrence Handle1:CAS:528:DyaK3sXhtFKjtrY%3D

    PubMed  CAS  Google Scholar 

  26. M Tokuda N Kurata A Mizoguchi M Inoh K Seto M Kinashi et al. (1994) ArticleTitleEffect of low-dose cyclosporin A on systemic lupus erythematosus disease activity Arthritis Rheum 37 551–8 Occurrence Handle8147933 Occurrence Handle10.1002/art.1780370416 Occurrence Handle1:STN:280:DyaK2c7pslOruw%3D%3D

    Article  PubMed  CAS  Google Scholar 

  27. LW Fu LY Yang WP Chen CY Lin (1998) ArticleTitleClinical efficacy of cyclosporin a neoral in the treatment of paediatric lupus nephritis with heavy proteinuria Br J Rheumatol 37 217–21 Occurrence Handle9569080 Occurrence Handle10.1093/rheumatology/37.2.217 Occurrence Handle1:CAS:528:DyaK1cXisVWnurY%3D

    Article  PubMed  CAS  Google Scholar 

  28. SJ Morton RJ Powell (2000) ArticleTitleAn audit of cyclosporin for systemic lupus erythematosus and related overlap syndromes: limitations of its use Ann Rheum Dis 59 487–9 Occurrence Handle10834868 Occurrence Handle10.1136/ard.59.6.487 Occurrence Handle1:CAS:528:DC%2BD3cXksVCktb0%3D

    Article  PubMed  CAS  Google Scholar 

  29. Y Erdem AU Yalcin O Oymak U Yasavul C Turgan S Caglar (1996) ArticleTitleCyclosporin A in lupus nephritis Nephron 72 332 Occurrence Handle8684556 Occurrence Handle1:STN:280:DyaK283ovVKltw%3D%3D Occurrence Handle10.1159/000188871

    Article  PubMed  CAS  Google Scholar 

  30. K Manger JR Kalden B Manger (1996) ArticleTitleCyclosporin A in the treatment of systemic lupus erythematosus: results of an open clinical study Br J Rheumatol 35 669–75 Occurrence Handle8670602 Occurrence Handle10.1093/rheumatology/35.7.669 Occurrence Handle1:CAS:528:DyaK28XmsFWksr4%3D

    Article  PubMed  CAS  Google Scholar 

  31. C Dostal V Tesar I Rychlik J Zabka J Vencovsky J Bartunkova et al. (1998) ArticleTitleEffect of 1 year cyclosporine A treatment on the activity and renal involvement of systemic lupus erythematosus: a pilot study Lupus 7 29–36 Occurrence Handle9493146 Occurrence Handle10.1191/096120398678919714 Occurrence Handle1:CAS:528:DyaK1cXht1ykurY%3D

    Article  PubMed  CAS  Google Scholar 

  32. LS Tam EK Li CB Leung KC Wong FM Lai A Wang et al. (1998) ArticleTitleLong-term treatment of lupus nephritis with cyclosporin A Q J Med 91 573–80 Occurrence Handle1:STN:280:DyaK1M7gvFOmuw%3D%3D

    CAS  Google Scholar 

  33. J Radhakrishnan CL Kunis V D'Agati GB Appel (1994) ArticleTitleCyclosporine treatment of lupus membranous nephropathy Clin Nephrol 42 147–54 Occurrence Handle7994932 Occurrence Handle1:STN:280:DyaK2M%2Foslanug%3D%3D

    PubMed  CAS  Google Scholar 

  34. AF Olshan DR Mattison TS Zwanenburg (1994) ArticleTitleInternational Commission for Protection Against Environmental Mutagens and Carcinogens. Cyclosporine A: review of genotoxicity and potential for adverse human reproductive and developmental effects Mutat Res 317 163–73 Occurrence Handle7511794 Occurrence Handle1:CAS:528:DyaK2cXjtFGjtrg%3D

    PubMed  CAS  Google Scholar 

  35. A Doria L Di Lenardo S Vario A Calligaro E Vaccaro PF Gambari (1992) ArticleTitleCyclosporin A in a pregnant patient affected with systemic lupus erythematosus Rheumatol Int 12 77–8 Occurrence Handle1411086 Occurrence Handle10.1007/BF00300981 Occurrence Handle1:STN:280:DyaK3s%2FjtVaisw%3D%3D

    Article  PubMed  CAS  Google Scholar 

  36. MM Hussein JM Mooij H Roujouleh (1993) ArticleTitleCyclosporine in the treatment of lupus nephritis including two patients treated during pregnancy Clin Nephrol 40 160–3 Occurrence Handle8403571 Occurrence Handle1:STN:280:DyaK2c%2FgslemtQ%3D%3D

    PubMed  CAS  Google Scholar 

  37. D Israel-Biet LH Noel MA Bach M Dardenne JF Bach (1983) ArticleTitleMarked reduction of DNA antibody production and glomerulopathy in thymulin (FTS-Zn) or cyclosporin A treated (NZB X NZW) F1 mice Clin Exp Immunol 54 359–65 Occurrence Handle6360436 Occurrence Handle1:CAS:528:DyaL2cXjvFM%3D

    PubMed  CAS  Google Scholar 

  38. S In M Dueymes S Appolinaire-Pilipenko F Sournies JF Labarre GJ Fournie (1990) ArticleTitleTreatment of end stage MRL-1pr/lpr mouse lupus disease by a cyclophosphazene derived drug and by cyclosporin A J Clin Lab Immunol 32 85–90 Occurrence Handle1967044 Occurrence Handle1:STN:280:DyaK38vgsl2jsw%3D%3D

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Division of Rheumatology and Clinical Immunology, Saitama Medical Center, Saitama Medical University, 1981 Kamoda, Tsujido-machi, Kawagoe, 350-8550, Japan

    Hiroe Ogawa, Hideto Kameda, Hayato Nagasawa, Naoya Sekiguchi, Hirofumi Takei, Kensei Tsuzaka, Koichi Amano & Tsutomu Takeuchi

Authors
  1. Hiroe Ogawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hideto Kameda
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hayato Nagasawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Naoya Sekiguchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hirofumi Takei
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kensei Tsuzaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Koichi Amano
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Tsutomu Takeuchi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hiroe Ogawa.

About this article

Cite this article

Ogawa, H., Kameda, H., Nagasawa, H. et al. Prospective study of low-dose cyclosporine A in patients with refractory lupus nephritis. Mod Rheumatol 17, 92–97 (2007). https://doi.org/10.1007/s10165-006-0545-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10165-006-0545-8

Key words

Search

Navigation